These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11515423)

  • 1. Effect of ICRF159 on the mammalian cell cycle: significance for its use in cancer chemotherapy.
    Hellmann K; Field EO
    J Natl Cancer Inst; 1970 Mar; 44(3):539-43. PubMed ID: 11515423
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and antitumor activity of guanylhydrazones from 6-(2,4-dichloro-5-nitrophenyl)imidazo[2,1-b]thiazoles and 6-pyridylimidazo[2,1-b]thiazoles(1).
    Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Farruggia G; Stefanelli C; Masotti L; Kunkel MW
    J Med Chem; 2006 Dec; 49(26):7897-901. PubMed ID: 17181173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
    Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L
    J Med Chem; 2007 Jul; 50(14):3167-72. PubMed ID: 17559205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening finds potential killer of cancer stem cells.
    Rowan K
    J Natl Cancer Inst; 2009 Nov; 101(21):1438-9. PubMed ID: 19828869
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo antitumor activity of chitosan nanoparticles.
    Qi L; Xu Z
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4243-5. PubMed ID: 16759859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cytotoxic activities of 2-alkyl-4,6-diheteroalkyl-1,3,5-triazines: new molecules in anticancer research.
    Menicagli R; Samaritani S; Signore G; Vaglini F; Dalla Via L
    J Med Chem; 2004 Sep; 47(19):4649-52. PubMed ID: 15341480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanism of cell death induced by chemotherapeutic agents].
    Saya H
    Brain Nerve; 2009 Jul; 61(7):843-7. PubMed ID: 19618862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis: mediator or mode of cell killing by anticancer agents?
    Brown JM; Wouters BG
    Drug Resist Updat; 2001 Apr; 4(2):135-6. PubMed ID: 11512523
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells.
    Jensen LH; Dejligbjerg M; Hansen LT; Grauslund M; Jensen PB; Sehested M
    BMC Pharmacol; 2004 Dec; 4():31. PubMed ID: 15575955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
    Yip KW; Mao X; Au PY; Hedley DW; Chow S; Dalili S; Mocanu JD; Bastianutto C; Schimmer A; Liu FF
    Clin Cancer Res; 2006 Sep; 12(18):5557-69. PubMed ID: 17000693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibitory effect of trans9, trans11 isomer of conjugated linoleic acid on the growth of human colon cancer cells.
    Beppu F; Hosokawa M; Tanaka L; Kohno H; Tanaka T; Miyashita K
    J Nutr Biochem; 2006 Dec; 17(12):830-6. PubMed ID: 16563722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.
    Tsang WP; Kwok TT
    Apoptosis; 2008 Oct; 13(10):1215-22. PubMed ID: 18758960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is cell death a critical end point for anticancer therapies or is cytostasis sufficient?
    Rixe O; Fojo T
    Clin Cancer Res; 2007 Dec; 13(24):7280-7. PubMed ID: 18094408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoscale tools to selectively destroy cancer cells.
    Boudreault PL; Arseneault M; Otis F; Voyer N
    Chem Commun (Camb); 2008 May; (18):2118-20. PubMed ID: 18438487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro drug resistance versus chemosensitivity: two sides of different coins.
    Fruehauf JP; Alberts DS
    J Clin Oncol; 2005 May; 23(15):3641-3; author reply 3646-8. PubMed ID: 15908686
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-based screening approach for antitumor drug leads which exploits sensitivity differences between normal and cancer cells: identification of two novel cell-cycle inhibitors.
    Vassilev LT; Kazmer S; Marks IM; Pezzoni G; Sala F; Mischke SG; Foley L; Berthel SJ
    Anticancer Drug Des; 2001 Feb; 16(1):7-17. PubMed ID: 11762646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles.
    Shedden K; Xie XT; Chandaroy P; Chang YT; Rosania GR
    Cancer Res; 2003 Aug; 63(15):4331-7. PubMed ID: 12907600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview: the art of cancer drug screening: molecular target versus milieu-based screens.
    Sawyers CL; Sausville EA
    Curr Opin Investig Drugs; 2002 Mar; 3(3):478-81. PubMed ID: 12054100
    [No Abstract]   [Full Text] [Related]  

  • 20. A cellular screening assay to test the ability of PKR to induce cell death in mammalian cells.
    Friedrich I; Eizenbach M; Sajman J; Ben-Bassat H; Levitzki A
    Mol Ther; 2005 Nov; 12(5):969-75. PubMed ID: 16084774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.